Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Assets
Cash and due from financial institutions	$ 5,998	$ 14,452
Federal funds sold and cash equivalents	80,737	27,661
Total cash and cash equivalents	86,735	42,113
Investment securities available for sale, at fair value	32,580	37,991
Investment securities held to maturity (fair value of $1,253 at September 30, 2018 and $2,468 at December 31, 2017)	1,099	2,268
Total investment securities	33,679	40,259
Loans held for sale	2,217	1,541
Loans, net of unearned income	1,179,849	1,011,717
Less: Allowance for loan losses	(17,918)	(16,533)
Net loans	1,161,931	995,184
Accrued interest receivable	4,869	4,025
Premises and equipment, net	6,874	7,025
Other real estate owned (OREO)	5,014	7,248
Restricted stock, at cost	5,858	6,172
Bank owned life insurance (BOLI)	25,654	25,196
Deferred tax asset	6,525	6,420
Other assets	2,634	2,269
Total Assets	1,341,990	1,137,452
Deposits
Noninterest-bearing deposits	236,030	124,356
Interest-bearing deposits	829,172	742,027
Total deposits	1,065,202	866,383
FHLBNY borrowings	104,650	114,650
Subordinated debentures	13,403	13,403
Accrued interest payable	1,211	719
Other liabilities	8,319	7,517
Total liabilities	1,192,785	1,002,672
Equity
Preferred stock, 1,000,000 shares authorized, $1,000 liquidation value Series B - non-cumulative convertible; 3,417 shares outstanding at September 30, 2018 and 15,971 shares outstanding at December 31, 2017	3,417	15,971
Common stock, $0.10 par value; authorized 15,000,000 shares; Issued: 10,678,855 shares at September 30, 2018 and 8,301,497 shares at December 31, 2017	1,068	830
Additional paid-in capital	110,599	81,940
Retained earnings	36,764	39,184
Accumulated other comprehensive loss	(961)	(130)
Treasury stock, at cost, 284,522 shares at September 30, 2018 and at December 31, 2017, respectively,	(3,015)	(3,015)
Total shareholders’ equity	147,872	134,780
Non-Controlling Interest	1,333	0
Total equity	149,205	134,780
Total liabilities and equity	$ 1,341,990	$ 1,137,452